Coronavirus outbreak: Rick Bright says he disagreed with health secretary’s directive to make Hydroxychloroquine widely available

Federal scientist Dr. Rick Bright was asked during his hearing before the House Committee on Energy and Commerce health subcommittee about his work with the FDA to get emergency authorization for the use of the drug Hydroxychloroquine to treat COVID-19. He said he received a directive from the health secretary’s office to put in place an expanded access protocol and make the drug available for Americans without the close supervision of a physician, and that’s when he decided he disagreed with that directive.